Pi Health

Pi Health is an oncology-focused health technology company that has developed an AI-native operating system for global drug development, designed to replace fragmented legacy clinical trial systems. Their core platform, FICS (Front-end Interoperable Capture System), integrates traditionally isolated functions—such as Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), and Electronic Trial Master Files (eTMF)—into a single, unified record. By embedding AI into operational workflows, the platform automates data entry from Electronic Medical Records (EMR) to EDC, facilitates protocol-driven study builds, and maintains a comprehensive, GxP-compliant audit trail. The company’s engineering, clinical, and regulatory teams work in tandem to improve trial speed, efficiency, and data quality from startup through closeout.

This technology is designed to help life sciences companies and research partners accelerate the development of lifesaving medicines and reach diverse patient populations more effectively. By providing a single source of truth, Pi Health eliminates the need for manual data reconciliation and reduces monitoring queries, aiming to make clinical trials faster, fairer, and more globally scalable. The company supports a global network of partners, including collaborations with major pharmaceutical firms like GSK and oncology centers across regions such as India, Brazil, and the United States. Founded in 2021 and headquartered in Cambridge, Massachusetts, the firm continues to grow its platform to address systemic inefficiencies in oncology research and clinical care.